Inventor
GOOD ANDREW C
US37 patents
⚠️ This page may combine multiple inventors who share the name “GOOD ANDREW C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS7659270B2Feb 9, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations98
US7759495B2Jul 20, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO58 citations94
US8642025B2Feb 4, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7906655B2Mar 15, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US9227961B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations84
US8846023B2Sep 30, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US9018390B2Apr 28, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US7902218B2Mar 8, 2011
Substituted tetrahydroisoquinolines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO5 citations62
US7338974B2Mar 4, 2008
Macrocyclic diaminopropanes as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO6 citations62
US9758487B2Sep 12, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US7612069B2Nov 3, 2009
Acyl guanidines as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
BIAL—R&D INVEST S A
7 patentsUS11091492B2Aug 17, 2021
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A5 citations83
US11932645B2Mar 19, 2024
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11453675B2Sep 27, 2022
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11400095B2Aug 2, 2022
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11351173B2Jun 7, 2022
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A3 citations72
US11345698B2May 31, 2022
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A3 citations72
US12116369B2Oct 15, 2024
Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators
BIAL—R&D INVEST S A0 citations62
BACHAND CAROL
6 patentsUS8574563B2Nov 5, 2013
Hepatitis C virus inhibitors
BACHAND CAROL18 citations92
US8303944B2Nov 6, 2012
Hepatitis C virus inhibitors
BACHAND CAROL36 citations92
US8147818B2Apr 3, 2012
Hepatitis C virus inhibitors
BACHAND CAROL22 citations92
US8492553B2Jul 23, 2013
Hepatitis C virus inhibitors
BACHAND CAROL11 citations84
US8288562B2Oct 16, 2012
Hepatitis C virus inhibitors
BACHAND CAROL9 citations84
US8093243B2Jan 10, 2012
Hepatitis C virus inhibitors
BACHAND CAROL5 citations62
LYSOSOMAL THERAPEUTICS INC
3 patentsUS10570135B2Feb 25, 2020
Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC13 citations93
US10751341B2Aug 25, 2020
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC12 citations85
US10786508B2Sep 29, 2020
Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC10 citations83